Literature DB >> 10864678

Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly.

Z Qiu1, J Yao, H Cao, S Gillam.   

Abstract

Rubella virus (RV) virions contain three structural proteins, a capsid protein that interacts with viral genomic RNA to form a nucleocapsid and two membrane glycoproteins, E2 and E1. We found that substitution of either an aspartic acid residue at Gly93 (G93D) or a glycine residue at Pro104 (P104G) in the internal hydrophobic domain of E1 affected virus infectivity but not virus assembly. Viruses carrying G93D and P104G mutations had impaired infectivity, reduced 1,000-fold and 10-fold, respectively. A revertant was isolated from the G93D mutant. Sequencing analysis showed that the substituted aspartic acid residue in G93D mutant had reverted to the original glycine residue, suggesting the involvement of Gly93 in membrane fusion during viral entry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864678      PMCID: PMC112174          DOI: 10.1128/jvi.74.14.6637-6642.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

4.  Mutational analysis, using a full-length rubella virus cDNA clone, of rubella virus E1 transmembrane and cytoplasmic domains required for virus release.

Authors:  J Yao; S Gillam
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Rubella virus maturation and production in two host cell systems.

Authors:  G Bardeletti; J Tektoff; D Gautheron
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

6.  Assembly of rubella virus structural proteins into virus-like particles in transfected cells.

Authors:  T C Hobman; M L Lundstrom; C A Mauracher; L Woodward; S Gillam; M G Farquhar
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

7.  Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

8.  Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity.

Authors:  D Yang; D Hwang; Z Qiu; S Gillam
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly.

Authors:  W A Duffus; P Levy-Mintz; M R Klimjack; M Kielian
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.

Authors:  M Kielian; M R Klimjack; S Ghosh; W A Duffus
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

View more
  3 in total

1.  Functional and evolutionary insight from the crystal structure of rubella virus protein E1.

Authors:  Rebecca M DuBois; Marie-Christine Vaney; M Alejandra Tortorici; Rana Al Kurdi; Giovanna Barba-Spaeth; Thomas Krey; Félix A Rey
Journal:  Nature       Date:  2013-01-06       Impact factor: 49.962

2.  Calcium-Dependent Rubella Virus Fusion Occurs in Early Endosomes.

Authors:  Mathieu Dubé; Loïc Etienne; Maximilian Fels; Margaret Kielian
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

3.  Rubella virus: first calcium-requiring viral fusion protein.

Authors:  Mathieu Dubé; Felix A Rey; Margaret Kielian
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.